Science-Based Nutraceuticals

v1 - vaccine enhancement

Glutrasol VE

Addressing Global Vaccination Enhancement

Glutrasol VE is a patented medical food we developed to address a chronic global health need for vaccine immuno-enhancement. 

In many developing countries, those in most desperate need of vaccination against potentially life-threatening diseases like malaria come to treatment facilities with immune systems so compromised due to environmental stress, poor nutrition or illness that the efficacy of the vaccines they receive is not optimized. By integrating the Glutrasol VE protocol with the vaccine regimen they receive, the long-term efficacy of that vaccine can be effectively enhanced. 

Based on chemistries that have been successful in increasing the efficacy of vaccines in thousands of animals for more than 25 years—by between 93% and 360% or more-- CortControl just received a US Patent for Glutrasol VE for human applications.

Related Reading

Additional Information for:

CortControl explores collaborations with Philanthropic Organizations to Bring New Technologies that can Solve Challenges in Treating Global Disease


CortControl is seeking research partners to complete necessary SSA studies for our Glutrasol VE product. Vaccine immuno-enhancement results will be used to secure FDA approval to use our Glutrasol VE product as a medical food.